Relief Therapeutics Holding SA (RLF) | Finanzwire

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

BRIEF

published on 12/16/2024 at 07:05, 5 days 12 hours ago

Relief Therapeutics Reports Promising Outcomes from PKU GOLIKE Trial

Biopharmaceutical Clinical Trial PKU GOLIKE Phenylketonuria Metabolic Control
PRESS RELEASE

published on 12/16/2024 at 07:00, 5 days 12 hours ago

Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Relief Therapeutics announces final readout of PKU GOLIKE clinical trial showing superior metabolic control during prolonged fasting in PKU patients. Results aim to promote awareness and adoption of PKU GOLIKE

Clinical Trial Relief Therapeutics PKU GOLIKE Phenylketonuria Metabolic Control
BRIEF

published on 12/13/2024 at 23:05, 7 days 20 hours ago

Relief Therapeutics to End SEC Reporting Obligations with Form 15F Filing

OTCQB SIX Swiss Exchange Relief Therapeutics SEC Reporting Form 15F
PRESS RELEASE

published on 12/13/2024 at 23:00, 7 days 20 hours ago

Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations
Relief Therapeutics announces filing of Form 15F to terminate SEC reporting obligations, maintaining listing on SIX Swiss Exchange and U.S. over-the-counter market

SIX Swiss Exchange Relief Therapeutics SEC Reporting Form 15F U.S. OTCQB
BRIEF

published on 11/11/2024 at 07:05, 1 month 10 days ago

Relief Therapeutics Reports Positive Outcomes in RLF-TD011 Trial for Epidermolysis Bullosa

Relief Therapeutics RLF-TD011 Clinical Trial Results Epidermolysis Bullosa Microbiome Diversity
PRESS RELEASE

published on 11/11/2024 at 07:00, 1 month 10 days ago

Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Relief Therapeutics reports positive final results from RLF-TD011 clinical trial for Epidermolysis Bullosa, showing effective wound healing and microbiome diversity improvements

Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Microbiome Diversity
BRIEF

published on 11/04/2024 at 07:05, 1 month 17 days ago

Relief Therapeutics and Renexxion Consider Reverse Merger

Biotechnology Shareholder Value Healthcare Reverse Merger Gastrointestinal Disorders
PRESS RELEASE

published on 11/04/2024 at 07:00, 1 month 17 days ago

Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger
Relief Therapeutics signs non-binding letter of intent with Renexxion for reverse merger, aiming to create a combined entity with an expanded therapeutic pipeline

Biopharmaceutical Relief Therapeutics Therapeutic Pipeline Reverse Merger Renexxion
BRIEF

published on 10/29/2024 at 07:05, 1 month 23 days ago

Relief Therapeutics Highlights PKU GOLIKE Findings

Patient Engagement Relief Therapeutics PKU GOLIKE Phenylketonuria Amino Acid Absorption
PRESS RELEASE

published on 10/29/2024 at 07:00, 1 month 23 days ago

Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE
Relief Therapeutics announced the publication of a Plain Language Summary on PKU GOLIKE for phenylketonuria management, highlighting findings on prolonged-release protein substitute with similarities to natural proteins

Medical Research Relief Therapeutics PKU GOLIKE Phenylketonuria Plain Language Summary

Accesswire

Published on 12/21/2024 at 01:30, 18 hours 8 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 8 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 33 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 38 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 20 hours 8 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 46 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 52 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 20 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days 1 hour ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE